Presentations
LUPUS IN 2050
Autoantibody testing 2050
Fritzler, Marvin
Autoimmune syndromes induced by adjuvants (ASIA), silicone implants, vaccination, and more-2050
Shoenfeld, Yehuda
PLENARY
2012 Guidelines for management of lupus nephritis
Hahn, Bevra
Demystifying neuropsychiatric lupus – Is it possible?
Hanly, John G.
Future trials: Less risky?
Merrill, Joan T.
Evidence based induction and maintenance therapy recommendations for lupus nephritis. Use of biologics
Lightstone, Liz
New treatments for SLE: how were they tested, and how are they used in clinical practice
Van Vollenhoven, Ronald F.
SLE clinical trials. Lessons learned: are all failed trials due to failed treatments?
Furie, Richard
Standard of care of lupus nephritis
Houssiau, Frédéric A.
SYMPOSIUM
Basic
Lupus neutrophils NET gain in understanding SLE pathogenesis
Kaplan, Mariana
Pedriatic
Gonadal function and preservation of reproductive fitness in childhood-onset systemic lupus erythematosus
Almeida Da Silva, Clovis A.
Therapy insight: cardiovascular disease in pediatric systemic lupus
Schanberg, Laura E.
Therapy of lupus nephritis in juvenile patients
Sandborg, Christy
Epidemiologic
Lessons from lupus epidemiology around the world. Networking in Europe
Cervera, Ricard
Lessons from lupus epidemiology around the world. The GLADEL experience
Catoggio, Luis
Lessons from lupus epidemiology: US (LUMINA)
Alarcon, Graciela S.
Genetic
Genetics of lupus: towards the identification of susceptibility genes in admixed populations with amerindian ancestry
Alarcón-Riquelme, Marta E.
Genetics of SLE: what it means for patients and physicians
Kimberly, Robert P.
IRF5 & cross-ancestry disease risk
Harley, John B.
INVITED LECTURE
Antimalarials revisited
Ruiz-Irastorza, Guillermo
Biomarkers for lupus: a critical perspective
Pisetsky, David S.
Derivation and validation of SLICC classification criteria for SLE
Petri, Michelle
Evidence for treatment of cutaneous lupus: a dermatologist approach
Werth, Victoria P.
Getting beyond description: explaining the causes of disparities by race/ethnicity in SLE
Yelin, Edward
Novel insights into diagnosis & treatment of anti-phospholipid syndrome
Meroni, Pier Luigi
The mosaic of autoimmunity. Infections genetics and autoantibodies
Shoenfeld, Yehuda
Understanding the challenge of low vitamin D and osteoporosis in lupus
Pereira, Rosa
UP TO DATE
Current thinking about prevention, management and outcomes of the neonatal lupus syndromes
Buyon, Jill
Challenges in the management of OB lupus patients
Levy, Roger
Lupus and malignancy: the good, the bad, & the unknown
Clarke, Ann
Lupus biopsy: the nephrologist's point of view
Lightstone, Liz
Systemic lupus international collaborating clinics: contributions to clinical practice
Urowitz, Murray
MEET THE PROFESSORS
Advancing the epidemiologic understanding of lupus with population-based studies: lessons from the Georgia lupus registry (GLR)
Drenkard, Cristina
Arthritis in systemic lupus erythematosus
Iacobelli, Sergio
CVD risk assessment and treatment. Practical approaches to management
Manzi, Susan
Developing strategies to address outcome disparities in SLE
Liang Metthew H.
Does the european perspectives for the management of SLE apply to LA patients. The lupus nephritis experience
Cervera, Ricard
Improving outcomes in lupus nephritis
Lightstone, Liz
Issues in pediatric lupus
Sandborg, Christy
Lupus nephritis
Ramsey-Goldman, Rosalind
Lupus in adolescents
Sánchez-Guerrero, Jorge
Management of cutaneous lupus
Werth, Victoria P.
Management of lupus glomerulonephritis
Doria, Andrea
Mortality in SLE – 2013
Urowitz, Murray
Nervous system lupus
Wallace, Daniel
Neuro-psychiatric SLE
Barile-Fabris, Leonor A.
Steroids & antimalarials use in lupus
Ruiz-Irastorza, Guillermo
The myth and reality of CNS involvement in SLE
Shoenfeld, Yehuda
THE YEAR IN REVIEW
ORAL PRESENTATIONS
BLyS and APRIL in Lupus Nephritis. A study of candidate biomarkers.
Dysregulated phagocytosis in Juvenile Systemic Lupus Erythematosus.
Final results from an open-label extension study of epratuzumab (SL0006)
French registry of immune congenital heart block: Maternal data analysis
Hippocampal atrophy in childhood-onset Systemic Lupus Erythematosus
Interferon-alpha May Impair Endothelial Repair Mechanisms in Patients with SLE
Long-Term Outcomes of Children Born to Women with Systemic Lupus Erythematosus
Lupus Anticoagulant at First Pregnancy Visit is Predictive of Pregnancy Loss in SLE
Mortality Rates among U.S. Medicaid Recipients with SLE, 2000-2006
Predictive Atherosclerotic Risk Factors At Inception in a Multicentre, Multinational Cohort
Provision of Quality Driven Care In Childhood-onset Systemic Lupus Erythematosus
SLE Cardiovascular Risk Equation
TNFAIP3 Expression is Regulated by the SLE Associated TT>A Variant
Which Lupus Trial Endpoints Best Reflect Clinical Judgment or Biomarker Improvement?
PATIENT CONGRESS
Como comenzar un exitoso grupo de apoyo de lupus. Como abogar persuasivamente por el lupus
Schofield, Kim
Calva y brillante como la luna. Diario de una loba contra el lupus
Athié, Laura
¿Debería poner atención especial al riesgo cardiovascular?
Eimon, Alicia
¿Cómo llegamos a enfermar? Y qué estrategias podemos usar para sanar
Lunic, Maria Cristina
Genetic and environmental factors in lupus
Cardiel, Mario H.
Lupus nephritis: what treatment options are the best for me and how I can help my doctor to better manage it?
Molina, Jose
Lupus y embarazo: la planificación anticipada y el control médico adecuado
Cervera, Ricard
Management of lupus
Alarcon, Graciela S.